125 related articles for article (PubMed ID: 12506591)
1. Dysbetalipoproteinaemia--clinical and pathophysiological features.
Blom DJ; Byrnes P; Jones S; Marais AD
S Afr Med J; 2002 Nov; 92(11):892-7. PubMed ID: 12506591
[TBL] [Abstract][Full Text] [Related]
2. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
Smelt AH
Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
[TBL] [Abstract][Full Text] [Related]
3. Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.
Marais AD; Solomon GA; Blom DJ
Crit Rev Clin Lab Sci; 2014 Feb; 51(1):46-62. PubMed ID: 24405372
[TBL] [Abstract][Full Text] [Related]
4. Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.
Hopkins PN; Wu LL; Schumacher MC; Emi M; Hegele RM; Hunt SC; Lalouel JM; Williams RR
Arterioscler Thromb; 1991; 11(5):1137-46. PubMed ID: 1680391
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic image. A woman with orange hand lines].
Bouwmans EM; Assouiki F
Ned Tijdschr Geneeskd; 2009; 153():B452. PubMed ID: 19857303
[TBL] [Abstract][Full Text] [Related]
6. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
[TBL] [Abstract][Full Text] [Related]
7. Dysbetalipoproteinemia and other lipid abnormalities related to apo E.
Cenarro A; Bea AM; Gracia-Rubio I; Civeira F
Clin Investig Arterioscler; 2021 May; 33 Suppl 2():50-55. PubMed ID: 34006354
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipoprotein profiles of normocholesterolemic and hypercholesterolemic homozygotes for apolipoprotein E2(Arg158-->Cys) compared.
Zhao SP; Smelt AH; Van den Maagdenberg AM; Van Tol A; Vroom TF; Gevers Leuven JA; Van der Laarse A; Van 't Hooft FM
Clin Chem; 1994 Aug; 40(8):1559-66. PubMed ID: 8044997
[TBL] [Abstract][Full Text] [Related]
9. [Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient].
Ziemer A; Göring HD
Hautarzt; 1993 Aug; 44(8):538-44. PubMed ID: 8376110
[TBL] [Abstract][Full Text] [Related]
10. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
[TBL] [Abstract][Full Text] [Related]
12. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
Smelt AH; de Beer F
Semin Vasc Med; 2004 Aug; 4(3):249-57. PubMed ID: 15630634
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.
Feussner G; Wagner A; Kohl B; Ziegler R
Clin Investig; 1993 May; 71(5):362-6. PubMed ID: 8508005
[TBL] [Abstract][Full Text] [Related]
15. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
Feussner G; Dobmeyer J; Nissen H; Hansen TS
Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
[TBL] [Abstract][Full Text] [Related]
16. Familial apolipoprotein E deficiency.
Schaefer EJ; Gregg RE; Ghiselli G; Forte TM; Ordovas JM; Zech LA; Brewer HB
J Clin Invest; 1986 Nov; 78(5):1206-19. PubMed ID: 3771793
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia).
Haffner SM; Kushwaha RS; Hazzard WR
Eur J Clin Invest; 1989 Oct; 19(5):486-90. PubMed ID: 2511026
[TBL] [Abstract][Full Text] [Related]
18. Potential role of insulin in the clearance of remnant lipoproteins in dysbetalipoproteinaemia.
Duell PB; Bierman EL
J Intern Med; 1991 Jan; 229(1):97-101. PubMed ID: 1995770
[TBL] [Abstract][Full Text] [Related]
19. Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia.
Murase T; Okubo M; Takeuchi I
J Clin Lipidol; 2010; 4(2):99-104. PubMed ID: 21122636
[TBL] [Abstract][Full Text] [Related]
20. Tuberous xanthomas associated with olanzapine therapy and hypertriglyceridemia in the setting of a rare apolipoprotein E mutation.
Sinnott BP; Mazzone T
Endocr Pract; 2006; 12(2):183-7. PubMed ID: 16690468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
